MarketCap
Facebook
X
TelegramAnnual report 2024
added 04-18-2026
ICON Public Limited Company DIO Ratio 2011-2026 | ICLR
Annual DIO Ratio ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 0.213 | 0.452 | 0.817 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.817 | 0.213 | 0.494 |
Quarterly DIO Ratio ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 0.19 | - | - | - | 0.35 | - | - | - | 0.29 | - | - | - | 0.22 | - | - | - | - | - | - | - | 0.44 | - | - | - | 0.36 | - | - | - | 0.34 | - | - | - | 0.46 | - | - | - | 0.68 | - | - | - | 0.79 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.79 | 0.19 | 0.412 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 17.26 | -7.0 % | $ 181 M |  China |
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
1.69 K | $ 1.34 | -17.79 % | $ 1.78 M |  USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 15.78 | -2.53 % | $ 477 M | USA |
 |
Agilent Technologies
A
|
97.1 | $ 112.09 | -1.02 % | $ 34.1 B | USA |
 |
Castle Biosciences
CSTL
|
47.2 | $ 19.05 | 0.9 % | $ 552 M | USA |
 |
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
137 | $ 139.97 | -2.28 % | $ 22.3 B | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
29.1 | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 19.83 | -3.22 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 94.74 | -2.0 % | $ 6.39 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Mettler-Toledo International
MTD
|
79 | $ 1 043.89 | 0.19 % | $ 21.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
42.8 | $ 3.6 | -0.69 % | $ 333 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
NeoGenomics
NEO
|
24.4 | $ 8.28 | -0.96 % | $ 1.06 B | USA |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 157.18 | -1.33 % | $ 7.79 B | USA |
 |
Natera
NTRA
|
25.8 | $ 186.22 | -5.43 % | $ 18.3 B | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 25.27 | -0.94 % | $ 24 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
82.1 | $ 92.95 | -5.79 % | $ 11.7 B | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 5.73 | -1.55 % | $ 239 M | USA |
 |
Personalis
PSNL
|
12.1 | $ 6.47 | -3.64 % | $ 577 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
Soleno Therapeutics
SLNO
|
1.02 K | $ 52.99 | -0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | Niderland |
 |
Twist Bioscience Corporation
TWST
|
51.5 | $ 49.3 | -6.89 % | $ 2.95 B | USA |
 |
Biomerica
BMRA
|
147 | $ 2.31 | -4.04 % | $ 5.31 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 251.18 | -1.12 % | $ 20.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
86.5 | $ 439.31 | -1.97 % | $ 166 B | USA |
 |
Trinity Biotech plc
TRIB
|
212 | $ 0.57 | -1.49 % | $ 205 M |  Irlanda |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K |  Israel |
 |
Waters Corporation
WAT
|
528 | $ 331.34 | -0.56 % | $ 19.7 B | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 8.27 | -1.9 % | $ 1.79 B | USA |